Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Name:	us-gaap_PrepaidExpenseCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_PrepaidExpenseNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77896938&loc=d3e25336-109308

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Additional milestone payment payable.

No definition available.

Name:	xene_AdditionalMilestonePaymentPayable
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Commitments and contingencies.

No definition available.

Name:	xene_CommitmentsAndContingenciesLineItems
Namespace Prefix:	xene_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Contractual obligation paid.

No definition available.

Name:	xene_ContractualObligationPaid
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Total aggregate costs related to services rendered to date by an entity.

No definition available.

Name:	xene_CostOfServicesRendered
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Future potential payments.

No definition available.

Name:	xene_FuturePotentialPayments
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

License manufacture and supply agreement upfront fee.

No definition available.

Name:	xene_LicenseManufactureAndSupplyAgreementUpfrontFee
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Upfront fee paid.

No definition available.

Name:	xene_UpfrontFeePaid
Namespace Prefix:	xene_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=xene_AssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xene_FirstOrderPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xene_FirstOrderPharmaceuticalsIncAndValeantPharmaceuticalsInternationalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=xene_ClinicalDevelopmentMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=xene_RegulatoryMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=xene_SalesBasedAndOtherMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=xene_PreCommercialAndSingleDigitPercentageRoyaltyOnCommercialSalesMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=xene_MedpaceClinicalDevelopmentServiceAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: